{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:10:03Z","timestamp":1778494203099,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1477-7827-12-88","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T09:01:19Z","timestamp":1410339679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome"],"prefix":"10.1186","volume":"12","author":[{"given":"Beata","family":"Seeber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Morandell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Lunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Dieplinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,10]]},"reference":[{"key":"1258_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein IF, Leventhal ML: Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935, 29: 181-191.","journal-title":"Am J Obstet Gynecol"},{"key":"1258_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K: Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012, 97: 28-38. 10.1016\/j.fertnstert.2011.09.024. e25","journal-title":"Fertil Steril"},{"key":"1258_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans SM, Pate KA: Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013, 6: 1-13.","journal-title":"Clin Epidemiol"},{"key":"1258_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R: Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7: 219-231. 10.1038\/nrendo.2010.217.","journal-title":"Nat Rev Endocrinol"},{"key":"1258_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg,","year":"2004","unstructured":"Rotterdam EA-SPcwg,: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19: 41-47.","journal-title":"Hum Reprod"},{"key":"1258_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dobrjansky A: Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989, 38: 1165-1174. 10.2337\/diab.38.9.1165.","journal-title":"Diabetes"},{"key":"1258_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE: Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005, 90: 1929-1935. 10.1210\/jc.2004-1045.","journal-title":"J Clin Endocrinol Metab"},{"key":"1258_CR8","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1210\/jc.2003-032237","volume":"89","author":"EO Talbott","year":"2004","unstructured":"Talbott EO, Zborowski JV, Rager JR, Boudreaux MY, Edmundowicz DA, Guzick DS: Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004, 89: 5454-5461. 10.1210\/jc.2003-032237.","journal-title":"J Clin Endocrinol Metab"},{"key":"1258_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3109\/09513590.2013.774362","volume":"29","author":"F Lunger","year":"2013","unstructured":"Lunger F, Wildt L, Seeber B: Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations. Gynecol Endocrinol. 2013, 29: 541-544. 10.3109\/09513590.2013.774362.","journal-title":"Gynecol Endocrinol"},{"key":"1258_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","volume":"375","author":"RH Eckel","year":"2010","unstructured":"Eckel RH, Alberti KG, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2010, 375: 181-183. 10.1016\/S0140-6736(09)61794-3.","journal-title":"Lancet"},{"key":"1258_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"key":"1258_CR12","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","volume":"27","author":"ES Ford","year":"2004","unstructured":"Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care. 2004, 27: 2444-2449. 10.2337\/diacare.27.10.2444.","journal-title":"Diabetes Care"},{"key":"1258_CR13","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP): Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002, 106: 3143-3421.","journal-title":"Circulation"},{"key":"1258_CR14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005, 28: 1769-1778. 10.2337\/diacare.28.7.1769.","journal-title":"Diabetes Care"},{"key":"1258_CR15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","volume":"119","author":"A Galassi","year":"2006","unstructured":"Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006, 119: 812-819. 10.1016\/j.amjmed.2006.02.031.","journal-title":"Am J Med"},{"key":"1258_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","volume":"49","author":"AS Gami","year":"2007","unstructured":"Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49: 403-414. 10.1016\/j.jacc.2006.09.032.","journal-title":"J Am Coll Cardiol"},{"key":"1258_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056\/NEJM199807233390404.","journal-title":"N Engl J Med"},{"key":"1258_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2003-0004","volume":"24","author":"RS Legro","year":"2003","unstructured":"Legro RS: Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr Rev. 2003, 24: 302-312. 10.1210\/er.2003-0004.","journal-title":"Endocr Rev"},{"key":"1258_CR19","volume-title":"Circ Cardiovasc Genet","author":"F Kronenberg","year":"2014","unstructured":"Kronenberg F, Kollerits B, Kiechl S, Lamina C, Kedenko L, Meisinger C, Willeit J, Huth C, Wietzorrek G, Altmann ME, Thorand B, Melmer A, D\u00e4hnhardt D, Santer P, Rathmann W, Paulweber B, Koenig W, Peters A, Adham IM, Dieplinger H: Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ Cardiovasc Genet. 2014, doi:10.1161\/CIRCGENETICS.113.000654, in press"},{"key":"1258_CR20","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1016\/S0021-9258(17)32429-8","volume":"269","author":"HS Lichenstein","year":"1994","unstructured":"Lichenstein HS, Lyons DE, Wurfel MM, Johnson DA, McGinley MD, Leidli JC, Trollinger DB, Mayer JP, Wright SD, Zukowski MM: Afamin is a new member of the albumin, a-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem. 1994, 269: 18149-18154.","journal-title":"J Biol Chem"},{"key":"1258_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/pr0500105","volume":"4","author":"L Jerkovic","year":"2005","unstructured":"Jerkovic L, Voegele AF, Chwatal S, Kronenberg F, Radcliffe CM, Wormald MR, Lobentanz EM, Ezeh B, Eller P, Dejori N, Dieplinger B, Lottspeich F, Sattler W, Uhr M, Mechtler K, Dwek RA, Rudd PM, Baier G, Dieplinger H: Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res. 2005, 4: 889-899. 10.1021\/pr0500105.","journal-title":"J Proteome Res"},{"key":"1258_CR22","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1021\/bi026513v","volume":"41","author":"AF Voegele","year":"2002","unstructured":"Voegele AF, Jerkovic L, Wellenzohn B, Eller P, Kronenberg F, Liedl KR, Dieplinger H: Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry. 2002, 41: 14532-14538. 10.1021\/bi026513v.","journal-title":"Biochemistry"},{"key":"1258_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-2006-924233","volume":"114","author":"Z Radikova","year":"2006","unstructured":"Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, Trnovec T, Langer P, Sebokova E, Klimes I: Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes. 2006, 114: 249-256. 10.1055\/s-2006-924233.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1258_CR24","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161\/CIRCULATIONAHA.105.169404.","journal-title":"Circulation"},{"key":"1258_CR25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961, 21: 1440-1447. 10.1210\/jcem-21-11-1440.","journal-title":"J Clin Endocrinol Metab"},{"key":"1258_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2265.1980.tb01372.x","volume":"12","author":"C Lejeune-Lenain","year":"1980","unstructured":"Lejeune-Lenain C, Cantraine F, Dufrasnes M, Prevot F, Wolter R, Franckson JR: An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia. Clin Endocrinol (Oxf). 1980, 12: 525-535. 10.1111\/j.1365-2265.1980.tb01372.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1258_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cca.2013.08.016","volume":"425","author":"B Dieplinger","year":"2013","unstructured":"Dieplinger B, Egger M, Gabriel C, Poelz W, Morandell E, Seeber B, Kronenberg F, Haltmayer M, Mueller T, Dieplinger H: Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta. 2013, 425: 236-241.","journal-title":"Clin Chim Acta"},{"issue":"Suppl 1","key":"1258_CR28","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.fertnstert.2006.04.010","volume":"86","author":"RS Legro","year":"2006","unstructured":"Legro RS: Type 2 diabetes and polycystic ovary syndrome. Fertil Steril. 2006, 86 (Suppl 1): S16-S17.","journal-title":"Fertil Steril"},{"key":"1258_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1385\/ENDO:30:1:19","volume":"30","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Kandarakis H, Legro RS: The role of genes and environment in the etiology of PCOS. Endocrine. 2006, 30: 19-26. 10.1385\/ENDO:30:1:19.","journal-title":"Endocrine"},{"key":"1258_CR30","first-page":"4075","volume":"82","author":"JE Nestler","year":"1997","unstructured":"Nestler JE, Jakubowicz DJ: Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab. 1997, 82: 4075-4079.","journal-title":"J Clin Endocrinol Metab"},{"key":"1258_CR31","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA: Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010, 95: 2038-2049. 10.1210\/jc.2009-2724.","journal-title":"J Clin Endocrinol Metab"},{"key":"1258_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1530\/EC-14-0053","volume":"3","author":"A Koninger","year":"2014","unstructured":"Koninger A, Edimiris P, Koch L, Enekwe A, Lamina C, Kasimir-Bauer S, Kimmig R, Dieplinger H: Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome. Endocr Connect. 2014, 3: 120-126. 10.1530\/EC-14-0053.","journal-title":"Endocr Connect"},{"key":"1258_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","volume":"106","author":"A Dokras","year":"2005","unstructured":"Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH: Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005, 106: 131-137. 10.1097\/01.AOG.0000167408.30893.6b.","journal-title":"Obstet Gynecol"},{"key":"1258_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mce.2012.10.029","volume":"373","author":"GW Bates","year":"2013","unstructured":"Bates GW, Legro RS: Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol. 2013, 373: 91-97. 10.1016\/j.mce.2012.10.029.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-12-88.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:46:08Z","timestamp":1630561568000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-12-88"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1258"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-12-88","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,10]]},"assertion":[{"value":"31 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"88"}}